Home Shop COAs Recon Guide Dosing Calc Contact Shop All →
JP Labs Research Guide · Melanocortin-Family Peptides

What is KPV?

KPV (Lysine-Proline-Valine) is a tripeptide corresponding to the three C-terminal amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). Despite sharing a lineage with well-known melanocortin peptides like PT-141 and MT-2, KPV's most studied activity — anti-inflammatory signaling via NF-κB inhibition — occurs largely independently of the classical melanocortin receptors those compounds depend on, making it a mechanistically distinct research tool.

Research Use Only. All information on this page is for educational and research reference purposes. JP Labs products are intended strictly for in vitro laboratory research. Not for human or veterinary use. Not FDA approved for any therapeutic purpose.

What KPV Is

KPV is the smallest fragment of alpha-MSH still associated with meaningful biological activity — just three amino acids (Lysine-Proline-Valine) taken from the hormone's C-terminus. Unlike the full alpha-MSH molecule or synthetic analogues like PT-141 and MT-2, KPV's research interest does not center on melanocortin receptor pharmacology. Instead, it has been studied primarily as an anti-inflammatory research tool, active in models where NF-κB signaling and mast cell activity drive tissue inflammation.

🔬 Key Identification
Class: Synthetic tripeptide (alpha-MSH C-terminal fragment) · 3 amino acids · Mechanism: NF-κB pathway inhibition, receptor-independent · Research category: Melanocortin-Family / Anti-Inflammatory · Available size: 10mg · $60

Mechanism of Action

KPV's most-cited research activity centers on suppression of the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway — a central transcription factor complex that drives the expression of pro-inflammatory cytokines across many cell types. By inhibiting NF-κB nuclear translocation, KPV has been studied for its ability to dampen downstream inflammatory cascades.

A second area of research interest is mast cell stabilization — KPV has been examined for its effect on limiting mast cell degranulation, a process central to allergic and inflammatory responses in skin and gut tissue.

Notably, both of these mechanisms have been observed in research models even when classical melanocortin receptors (MC1R–MC5R) are blocked or absent, which is the basis for describing KPV's activity as largely receptor-independent.

"What makes KPV interesting as a research tool isn't that it came from alpha-MSH — it's that its anti-inflammatory activity doesn't require the melanocortin receptor signaling that alpha-MSH and its other analogues depend on."
JP Labs Research Notes

KPV vs PT-141 and MT-2: Receptor-Independent Activity

PT-141 and MT-2 are both melanocortin receptor agonists — every one of their studied effects (central arousal signaling for PT-141, melanogenesis and appetite modulation for MT-2) depends on binding and activating MC3R/MC4R or MC1R. KPV stands apart from both:

ParameterKPVPT-141 / MT-2
Receptor dependencyLargely independent of MC1R–MC5RDirectly dependent on MC3R/MC4R (PT-141) or MC1R/MC3R/MC4R (MT-2)
Primary studied effectNF-κB inhibition, anti-inflammatoryCNS arousal signaling (PT-141) or melanogenesis/appetite (MT-2)
Research categoryAnti-inflammatory / immunomodulatorySexual health / CNS or dermatological melanocortin research
Typical research modelsGut and skin inflammation modelsArousal behavior models (PT-141), pigmentation models (MT-2)

This distinction matters for research design: because KPV's anti-inflammatory effects persist independent of melanocortin receptor status, it can be used as a comparative or control tool alongside receptor-dependent compounds like PT-141 or MT-2 to help separate receptor-mediated effects from receptor-independent ones. See our What is PT-141 guide and What is MT-2 guide for a full breakdown of those receptor-dependent compounds.

📦 Also available from JP Labs
PT-141 Bremelanotide — 10mg — $50 · View product →
MT-2 Melanotan 2 — 10mg — $30 · View product →

Research Applications

KPV is most often referenced in research investigating gut inflammation (including inflammatory bowel disease models) and skin inflammation, where NF-κB-driven cytokine production and mast cell activity are central to the pathology being studied. It is also combined with other tissue-repair-focused peptides — such as in the KLOW blend, which pairs KPV's anti-inflammatory activity with GHK-Cu, BPC-157, and TB-500 for combined tissue-remodeling research.

For research use only. All products sold by JP Labs are intended strictly for in vitro laboratory research. Not for human or veterinary use. Not FDA approved for any therapeutic purpose.

Reconstitution for Research

KPV is supplied as a lyophilized (freeze-dried) powder and must be reconstituted with Bacteriostatic Water before use in research protocols.

Standard protocol for the 10mg vial: Add 2 mL Bacteriostatic Water for a concentration of 5 mg/mL. Inject the BAC Water slowly down the vial wall and swirl gently — do not shake. The solution should be clear and colorless. Refrigerate at 2–8°C after reconstitution. Stable 28–42 days.

For full reconstitution parameters and a dosing calculator that computes exact draw volumes, visit our Reconstitution Guide and Dosing Calculator.

Frequently Asked Questions

What is KPV?
KPV (Lysine-Proline-Valine) is a tripeptide corresponding to the three C-terminal amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). It is studied for anti-inflammatory activity — specifically NF-κB pathway inhibition and mast cell stabilization — that occurs largely independently of classical melanocortin receptor (MC1R–MC5R) activation.
How is KPV different from PT-141 and MT-2?
PT-141 and MT-2 are both melanocortin receptor agonists — their effects (arousal, melanogenesis) depend on binding and activating MC3R/MC4R or MC1R. KPV's anti-inflammatory activity appears to occur largely independently of those receptors, making it a mechanistically distinct research tool despite sharing an origin with the alpha-MSH family.
What does "receptor-independent" mean for KPV research?
It means KPV's anti-inflammatory effects can be studied without the confound of melanocortin receptor activation — no expected pigmentation, appetite, or CNS arousal signaling as seen with full-length alpha-MSH, PT-141, or MT-2. This isolates the inflammatory pathway from the receptor-mediated effects associated with those other compounds.
What research applications is KPV used for?
KPV is studied in models of gut and skin inflammation, NF-κB pathway inhibition, and mast cell stabilization. It is frequently referenced in inflammatory bowel disease and dermatological inflammation research models.
How do I reconstitute KPV?
Reconstitute the 10mg vial with 2 mL Bacteriostatic Water for a concentration of 5 mg/mL. Inject the BAC Water slowly down the vial wall and swirl gently — do not shake. Refrigerate at 2–8°C after reconstitution; stable 28–42 days.
Regulatory Notice

None of the statements on this website have been reviewed or approved by the U.S. Food and Drug Administration. JP Labs products are not intended to diagnose, treat, cure, or prevent any disease or medical condition. All products are sold strictly for in vitro laboratory research purposes. They are not for human or animal use of any kind. DiPerna Services, LLC d/b/a JP Labs is not a compounding pharmacy or outsourcing facility as defined under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.